new version V2017

nontaxane microtubule dynamics inhibitor

Eribulin      

TrialStudied treatmentControl treatmentpatientsROBResultNCT

advanced breast cancer (metastatic)

eribulin
EMBRACE (Cortes), 2011eribulintreatment of physician Risk of bias ConclusiveNCT00388726
Vahdat, 2013eribulinixabepilone Exploratory - NCT00879086
Trial 301 (Kaufman), 2015eribulincapecitabine Risk of bias NegativeNCT00337103
NCT02037529 ongoing eribulinpaclitaxel Risk of bias - NCT02037529
SCRI BRE 197 ongoing eribulin+cyclophosphamidedocetaxel+cyclophosphamide - NCT01527487
2014-0857 ongoing eribulin+gemcitabinepaclitaxel+gemcitabine Exploratory - NCT02263495
E7389-C086-304 ongoing eribulinvinorelbine Exploratory - NCT02225470